Clinical Trial Update: Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on intensification regimen for previously untreated, resectable, advanced squamous cell head and neck cancer; study terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-11-26